Bristol Myers acquires cell therapy partner 2seventy bio for about $286 million Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker ...
Regeneron Pharmaceuticals Inc. closed 44.49% short of its 52-week high of $1,211.20, which the company reached on August 27th ...
San Diego, California--(Newsfile Corp. - February 4, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback